David C. Myles, CH. DISCOV. & NON-CLIN Development Officer at Olema Pharmaceuticals, Inc. (OLMA), sold 20,541 shares at $15.02 ($312K) on 2023-11-01, disclosed to the SEC on 2023-11-03.
Scheduled sale ($312k) by CH. DISCOV. & NON-CLIN Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.02 | 6,668 | $100K | 32.1% |
| 2 | $15.02 | 6,668 | $100K | 32.1% |
| 3 | $15.36 | 3,332 | $51K | 16.4% |
| 4 | $15.36 | 3,332 | $51K | 16.4% |
| 5 | $17.51 | 541 | $9K | 3.0% |
| Total | $15.20 avg | 20,541 |
| $312K |
| 100% |
| Filing → |
| OLMA | SELL | 2024-12-11 | $467K | — | Filing → |
| OLMA | SELL | 2023-11-22 | $389K | — | Filing → |
| OLMA | SELL | 2023-11-13 | $4K | — | Filing → |